1857 Final results of a phase II study evaluating oral vinorelbine as a single-agent as first-line chemotherapy for metastatic breast cancer patients with bone metastases (NorBreast-228 trial)

Autor:	G. Villanova, Nicole Tubiana-Mathieu, Enrique Espinosa, Guenther G. Steger, P. Landreau, M. Blasinska, A. Ardizzoia, Francesco Giotta, A. Dominguez, N. Dobrovolskaya
Rok vydání:	2015
Předmět:	Oncology Cancer Research medicine.medical_specialty business.industry Phases of clinical research medicine.disease Vinorelbine Metastatic breast cancer Internal medicine medicine Single agent First line chemotherapy business medicine.drug
Zdroj:	European Journal of Cancer. 51:S284
ISSN:	0959-8049
DOI:	10.1016/s0959-8049(16)30807-3
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::5524b6154d7ad903b4ebf757af79ba6f https://doi.org/10.1016/s0959-8049(16)30807-3 Zobrazit plný text záznamu Full Text from ScienceDirect